| Name | Title | Contact Details |
|---|
BHS Corrugated – leading provider of solutions for the corrugated industry BHS Corrugated is the leading provider of solutions for the corrugated industry with 3,000 employees at headquarters in Weiherhammer, Germany as well as in more than 20 countries. As Lifecycle Partner, BHS Corrugated is consistently strong across the entire product and service range: from development and production, to installation and maintenance, to a variety of innovative Lifecycle Service solutions in the areas of corrugating rolls, individual machines, complete corrugators, industry 4.0, logistics and soon to come digital print in- and outside the corrugator. Significant aspects of digitalization, primarily regarding the optimization of process parameters and increasing degrees of automation and production efficiency, have been central issues of BHS Corrugated for many years. To meet the requirements of its customers as precisely as possible and to be always state-of-the-art, BHS Corrugated reinvests close to 5 percent of its turnover in research and development. In addition to its core business, BHS Corrugated supports different social projects, for example the familys own foundation "Angels for Children" or the "Lars und Christian Engel Stiftung (LUCE Trust)", which supports technological and economic development in the region. Contact: BHS Corrugated Maschinen- und Anlagenbau GmbH Paul-Engel-Str. 1 92729 Weiherhammer info@bhs-world.com Tel. +49 9605 919 0 bhs-world.com
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Argo Group is a U.S.-focused underwriter of specialty insurance products in the property and casualty market. We offer a full line of products and services designed to meet the unique coverage and claims-handling needs of businesses. Since 1957, we share a firm commitment to working together with independent agents, wholesale brokers and retail brokerage partners to deliver innovative products for niche markets. Headquartered in New York, were a diverse company with multiple offices in the United States. Our belief that the companys success is linked to our employees drives our commitment to creating an environment and culture of respect where everyone can thrive. We value helping the communities around us, growing alongside our employees through innovation and creating a workplace with work-life balance. Fraud Alert Argo Group is aware of a fraud scam involving false job postings and unsolicited employment offers using our brand. These communications often include hyperlinks and request personal information. If you have any questions about the legitimacy of a job posting, please view all openings here on our website. If you are approached by someone claiming to represent Argo Group, please contact us at either (888) 864-3422 or siuconsults@argogroupus.com.
Our main practice areas include Employment Law, Intellectual Property Law, Wills, Trusts & Asset Protection, Business Law, and General Civil Litigation. We have been in business for over twenty years, and our stellar reputation is best reflected in our reviews.
First branch of Banka Kombëtare Tregtare was established in Durrës on 29 November 1925, in the historical building where todays BKT Durrës Branch is situated. This building actually represents the oldest Albanian financial institution in the country. Banka Kombëtare Tregtare (BKT), with todays name, was established in January 1993, after the merging of the Albanian Commercial Bank (ACB) and the National Bank of Albania (NBA). The NBA on the other hand was established in 1992 as a result of a second sub-division of the State Bank of Albania. The NBA was set up to manage the domestic trading activity of the State-owned entities. The assets and liabilities from the activities of these two entities were transferred to BKT accounts since it was first established. Banka Kombëtare Tregtare was established as a Joint Stock Company in July 1997, with assets reaching ALL 2.7 billion. In February 2003, with the decision of the Shareholders General Meeting, the paid-up capital reached the amount of US$ 14, 64 million, turning BKT into the most capitalized bank in the whole Albanian banking system. The year 2006 started with a new vision for BKT. With the authorization of the Bank of Albania and pursuant to the specific court decision issued on June 9, 2006, it was approved the transfer of 60% plus 2 of the BKT shares possessed by Kent Bank in favour of Calik-Seker Konsorsiyum Yatirim A.S. On September 3, BKT opened its branch in Kosova and since that time, BKT Kosova has already opened 27 branches, ranking Banka Kombëtare Tregtare as the largest Albanian bank in the region. On June 30, 2009 Çalik Financial Services buys to IFC and EBRD shares being in this way the only BKT shareholder owning 100 % of the shares. On 30th April 2018 Banka Kombëtare Tregtare Kosova Branch, changes its status from Branch of a Foreign Bank to a subsidiary Bank. Now, its banking license has changed from Banka Kombëtare Tregtare Kosova Branch, to Banka Kombëtare Tregtare Kosovë J.S.C.